These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8718569)

  • 21. Assessment of the efficiency of treatment of dyslipidaemia in renal outpatients.
    Harris K; Thomas M; Short C; Moore R
    J Nephrol; 2002; 15(3):263-9. PubMed ID: 12113597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of diabetic dyslipidemia.
    Del Pilar Solano M; Goldberg RB
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):1-25, v. PubMed ID: 15752919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of coronary heart disease in analgesic nephropathy: relation to hypertension, hypertriglyceridemia and combined hyperlipidemia.
    Kaladelfos G; Edwards KD
    Nephron; 1976; 16(5):388-400. PubMed ID: 1264311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atherosclerosis and arteriosclerosis of the small vessels in chronic renal insufficiency and after transplantation: lipid factors].
    Boizel R
    Nephrologie; 2000; 21(7):329-32. PubMed ID: 11200602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in drug treatment of dyslipidemia: focus on atorvastatin.
    Davignon J
    Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Corsini A; Holdaas H
    Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is hyperlipidemia a factor in the progression of renal failure?].
    Geiger H
    Z Kardiol; 1993; 82 Suppl 4():35-8. PubMed ID: 8147060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipid risk factors of atherosclerosis: who, when, how to treat?].
    Foubert L; Dejager S; Bruckert E; Turpin G
    Ann Endocrinol (Paris); 1997; 58(4):275-82. PubMed ID: 9436473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hyperlipidemia in chronic progressive renal disease.
    Kasiske BL; O'Donnell MP; Kim Y; Keane WF
    Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):602-8. PubMed ID: 7859023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs.
    Stacy TA; Egger A
    J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid changes and statins in chronic renal insufficiency and dialysis.
    Wanner C; Krane V; Metzger T; Quaschning T
    J Nephrol; 2001; 14 Suppl 4():S76-80. PubMed ID: 11798151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital.
    Sangsawang T; Sriwijitkamol A
    Vasc Health Risk Manag; 2015; 11():563-7. PubMed ID: 26604773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of dyslipidemia in adults.
    Ahmed SM; Clasen ME; Donnelly JE
    Am Fam Physician; 1998 May; 57(9):2192-2204, 2207-8. PubMed ID: 9606309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter: Renal failure, hypertriglyceridemia, and coronary disease.
    Ghosh P; Evans DB
    N Engl J Med; 1974 Aug; 291(8):417. PubMed ID: 4603174
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis).
    Paramsothy P; Knopp RH; Bertoni AG; Blumenthal RS; Wasserman BA; Tsai MY; Rue T; Wong ND; Heckbert SR
    J Am Coll Cardiol; 2010 Sep; 56(13):1034-41. PubMed ID: 20846602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.